BACKGROUND: Chronic upper extremity impairment due to stroke has significant medical, psychosocial, and financial consequences, but few studies have examined the effectiveness of rehabilitation therapy during the chronic stroke period. OBJECTIVE: . To test the safety and efficacy of the MIT-Manus robotic device for chronic upper extremity impairment following stroke. METHODS: . The VA Cooperative Studies Program initiated a multicenter, randomized, controlled trial in November 2006 (VA ROBOTICS). Participants with upper extremity impairment >/=6 months poststroke were randomized to robot-assisted therapy (RT), intensive comparison therapy (ICT), or usual care (UC). RT and ICT consisted of three 1-hour treatment sessions per week for 12 weeks. The primary outcome was change in the Fugl-Meyer Assessment upper extremity motor function score at 12 weeks relative to baseline. Secondary outcomes included the Wolf Motor Function Test and the Stroke Impact Scale. RESULTS: . A total of 127 participants were randomized: 49 to RT, 50 to ICT, and 28 to UC. The majority of participants were male (96%), with a mean age of 65 years. The primary stroke type was ischemic (85%), and 58% of strokes occurred in the anterior circulation. Twenty percent of the participants reported a stroke in addition to their index stroke. The average time from the index stroke to enrollment was 56 months (range, 6 months to 24 years). The mean Fugl-Meyer score at entry was 18.9. CONCLUSIONS: . VA ROBOTICS demonstrates the feasibility of conducting multicenter clinical trials to rigorously test new rehabilitative devices before their introduction to clinical practice. The results are expected in early 2010.
RCT Entities:
BACKGROUND:Chronic upper extremity impairment due to stroke has significant medical, psychosocial, and financial consequences, but few studies have examined the effectiveness of rehabilitation therapy during the chronic stroke period. OBJECTIVE: . To test the safety and efficacy of the MIT-Manus robotic device for chronic upper extremity impairment following stroke. METHODS: . The VA Cooperative Studies Program initiated a multicenter, randomized, controlled trial in November 2006 (VA ROBOTICS). Participants with upper extremity impairment >/=6 months poststroke were randomized to robot-assisted therapy (RT), intensive comparison therapy (ICT), or usual care (UC). RT and ICT consisted of three 1-hour treatment sessions per week for 12 weeks. The primary outcome was change in the Fugl-Meyer Assessment upper extremity motor function score at 12 weeks relative to baseline. Secondary outcomes included the Wolf Motor Function Test and the Stroke Impact Scale. RESULTS: . A total of 127 participants were randomized: 49 to RT, 50 to ICT, and 28 to UC. The majority of participants were male (96%), with a mean age of 65 years. The primary stroke type was ischemic (85%), and 58% of strokes occurred in the anterior circulation. Twenty percent of the participants reported a stroke in addition to their index stroke. The average time from the index stroke to enrollment was 56 months (range, 6 months to 24 years). The mean Fugl-Meyer score at entry was 18.9. CONCLUSIONS: . VA ROBOTICS demonstrates the feasibility of conducting multicenter clinical trials to rigorously test new rehabilitative devices before their introduction to clinical practice. The results are expected in early 2010.
Authors: Janis J Daly; Neville Hogan; Elizabeth M Perepezko; Hermano I Krebs; Jean M Rogers; Kanu S Goyal; Mark E Dohring; Eric Fredrickson; Joan Nethery; Robert L Ruff Journal: J Rehabil Res Dev Date: 2005 Nov-Dec
Authors: Huanguang Jia; Yu Zheng; Dean M Reker; Diane C Cowper; Samuel S Wu; W Bruce Vogel; Gail C Young; Pamela W Duncan Journal: Stroke Date: 2006-12-28 Impact factor: 7.914
Authors: Susan E Fasoli; Hermano I Krebs; Mark Ferraro; Neville Hogan; Bruce T Volpe Journal: Neurorehabil Neural Repair Date: 2004-06 Impact factor: 3.919
Authors: Todd H Wagner; Albert C Lo; Peter Peduzzi; Dawn M Bravata; Grant D Huang; Hermano I Krebs; Robert J Ringer; Daniel G Federman; Lorie G Richards; Jodie K Haselkorn; George F Wittenberg; Bruce T Volpe; Christopher T Bever; Pamela W Duncan; Andrew Siroka; Peter D Guarino Journal: Stroke Date: 2011-07-14 Impact factor: 7.914
Authors: Emily M Mugler; Goran Tomic; Aparna Singh; Saad Hameed; Eric W Lindberg; Jon Gaide; Murad Alqadi; Elizabeth Robinson; Katherine Dalzotto; Camila Limoli; Tyler Jacobson; Jungwha Lee; Marc W Slutzky Journal: Neurorehabil Neural Repair Date: 2019-03-19 Impact factor: 3.919
Authors: Fabrisia Ambrosio; Michael L Boninger; Clifford E Brubaker; Anthony Delitto; William R Wagner; Richard K Shields; Steven L Wolf; Thomas A Rando Journal: J Rehabil Res Dev Date: 2013
Authors: Michelle Woodbury; Craig A Velozo; Paul A Thompson; Kathye Light; Gitendra Uswatte; Edward Taub; Carolee J Winstein; David Morris; Sarah Blanton; Deborah S Nichols-Larsen; Steven L Wolf Journal: Neurorehabil Neural Repair Date: 2010-07-08 Impact factor: 3.919
Authors: Bruce T Volpe; Patricio T Huerta; Johanna L Zipse; Avrielle Rykman; Dylan Edwards; Laura Dipietro; Neville Hogan; Hermano I Krebs Journal: Arch Neurol Date: 2009-09